{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T05:33:37Z","timestamp":1793252017610,"version":"4.5.0"},"reference-count":149,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transplantation"],"published-print":{"date-parts":[[2018,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Kidney donors face a small but definite risk of end-stage renal disease 15 to 30 years postdonation. The development of proteinuria, hypertension with gradual decrease in kidney function in the donor after surgical resection of 1 kidney, has been attributed to hyperfiltration. Genetic variations, physiological adaptations, and comorbidities exacerbate the hyperfiltration-induced loss of kidney function in the years after donation. A focus on glomerular hemodynamics and capillary pressure has led to the development of drugs that target the renin-angiotensin-aldosterone system (RAAS), but these agents yield mixed results in transplant recipients and donors. Recent work on glomerular biomechanical forces highlights the differential effects of tensile stress and fluid flow shear stress (FFSS) from hyperfiltration. Capillary wall stretch due to glomerular capillary pressure increases tensile stress on podocyte foot processes that cover the capillary. In parallel, increased flow of the ultrafiltrate due to single-nephron glomerular filtration rate elevates FFSS on the podocyte cell body. Although tensile stress invokes the RAAS, FFSS predominantly activates the cyclooxygenase 2-prostaglandin E<jats:sub>2<\/jats:sub>-EP<jats:sub>2<\/jats:sub> receptor axis. Distinguishing these 2 mechanisms is critical, as current therapeutic approaches focus on the RAAS system. A better understanding of the biomechanical forces can lead to novel therapeutic agents to target FFSS through the cyclooxygenase 2-prostaglandin E<jats:sub>2<\/jats:sub>-EP<jats:sub>2<\/jats:sub> receptor axis in hyperfiltration-mediated injury. We present an overview of several aspects of the risk to transplant donors and discuss the relevance of FFSS in podocyte injury, loss of glomerular barrier function leading to albuminuria and gradual loss of renal function, and potential therapeutic strategies to mitigate hyperfiltration-mediated injury to the remaining kidney.<\/jats:p>","DOI":"10.1097\/tp.0000000000002304","type":"journal-article","created":{"date-parts":[[2018,5,31]],"date-time":"2018-05-31T02:44:17Z","timestamp":1527734657000},"page":"1624-1635","source":"Crossref","is-referenced-by-count":62,"title":["Hyperfiltration-mediated Injury in the Remaining Kidney of a Transplant Donor"],"prefix":"10.1097","volume":"102","author":[{"given":"Tarak","family":"Srivastava","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sundaram","family":"Hariharan","sequence":"additional","affiliation":[{"name":"Department of Medicine and Surgery, Thomas E Starzl Transplant Institute, Pittsburgh, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uri S.","family":"Alon","sequence":"additional","affiliation":[{"name":"Section of Nephrology, Children's Mercy Hospital and University of Missouri at Kansas City, Kansas City, MO."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen T.","family":"McCarthy","sequence":"additional","affiliation":[{"name":"Kidney Institute, University of Kansas Medical Center, Kansas City, KS."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ram","family":"Sharma","sequence":"additional","affiliation":[{"name":"Renal Research, Research and Development, Kansas City VA Medical Center, Kansas City, MO."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashraf","family":"El-Meanawy","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Medical College of Wisconsin, Milwaukee, WI."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia J.","family":"Savin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mukut","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"bib1-20231002","doi-asserted-by":"crossref","first-page":"276","DOI":"10.7326\/M17-1235","article-title":"Mid- and long-term health risks in living kidney donors: a systematic review and meta-analysis","volume":"168","year":"2018","journal-title":"Ann Intern Med"},{"key":"bib2-20231002","doi-asserted-by":"crossref","first-page":"185","DOI":"10.7326\/0003-4819-145-3-200608010-00006","article-title":"Meta-analysis: risk for hypertension in living kidney donors","volume":"145","year":"2006","journal-title":"Ann Intern Med"},{"key":"bib3-20231002","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1038\/sj.ki.5001819","article-title":"Proteinuria and reduced kidney function in living kidney donors: a systematic review, meta-analysis, and meta-regression","volume":"70","year":"2006","journal-title":"Kidney Int"},{"key":"bib4-20231002","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/ki.2013.460","article-title":"Long-term risks for kidney donors","volume":"86","year":"2014","journal-title":"Kidney Int"},{"key":"bib5-20231002","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1001\/jama.2013.285141","article-title":"Risk of end-stage renal disease following live kidney donation","volume":"311","year":"2014","journal-title":"JAMA"},{"key":"bib6-20231002","first-page":"49","article-title":"Glomerular filtration rate, hypertension and proteinuria after renal ablation: a long-term follow-up study in kidney donors","volume":"108","year":"1988","journal-title":"Scand J Urol Nephrol Suppl"},{"key":"bib7-20231002","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1056\/NEJMoa1510491","article-title":"Kidney-failure risk projection for the living kidney-donor candidate","volume":"374","year":"2016","journal-title":"N Engl J Med"},{"key":"bib8-20231002","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1038\/ki.1996.265","article-title":"The hyperfiltration theory: a paradigm shift in nephrology","volume":"49","year":"1996","journal-title":"Kidney Int"},{"key":"bib9-20231002","first-page":"F324","article-title":"Nephron adaptation to renal injury or ablation","volume":"249","year":"1985","journal-title":"Am J Physiol"},{"key":"bib10-20231002","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1007\/BF00858530","article-title":"Glomerular adaptation in uninephrectomized young rats","volume":"3","year":"1989","journal-title":"Pediatr Nephrol"},{"key":"bib11-20231002","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1748-1716.1991.tb09109.x","article-title":"The contribution of ultrafiltration pressure for glomerular hyperfiltration in young nephrectomized rats","volume":"141","year":"1991","journal-title":"Acta Physiol Scand"},{"key":"bib12-20231002","doi-asserted-by":"crossref","first-page":"R975","DOI":"10.1152\/ajpregu.00693.2005","article-title":"Modulation of single-nephron GFR in the db\/db mouse model of type 2 diabetes mellitus","volume":"290","year":"2006","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"bib13-20231002","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/ki.1983.143","article-title":"Selective deep nephron hyperfiltration in uninephrectomized spontaneously hypertensive rats","volume":"24","year":"1983","journal-title":"Kidney Int"},{"key":"bib14-20231002","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1172\/JCI106056","article-title":"Mechanism of change in the excretion of sodium per nephron when renal mass is reduced","volume":"48","year":"1969","journal-title":"J Clin Invest"},{"key":"bib15-20231002","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1053\/j.ajkd.2015.01.019","article-title":"A prospective controlled study of living kidney donors: three-year follow-up","volume":"66","year":"2015","journal-title":"Am J Kidney Dis"},{"key":"bib16-20231002","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1172\/JCI78885","article-title":"Longitudinal study of living kidney donor glomerular dynamics after nephrectomy","volume":"125","year":"2015","journal-title":"J Clin Invest"},{"key":"bib17-20231002","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1038\/ki.1984.112","article-title":"Hypertension and proteinuria: long-term sequelae of uninephrectomy in humans","volume":"25","year":"1984","journal-title":"Kidney Int"},{"key":"bib18-20231002","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.urolonc.2010.04.005","article-title":"Kidney function following nephrectomy: similitude and discrepancies between kidney cancer and living donation","volume":"30","year":"2012","journal-title":"Urol Oncol"},{"key":"bib19-20231002","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1681\/ASN.2015091018","article-title":"Renal function profile in white kidney donors: The first 4 decades","volume":"27","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"bib20-20231002","doi-asserted-by":"crossref","first-page":"e3847","DOI":"10.1097\/MD.0000000000003847","article-title":"A meta-analysis of renal outcomes in living kidney donors","volume":"95","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"bib21-20231002","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/j.transproceed.2008.03.104","article-title":"Age, gender, race, and associations with kidney failure following living kidney donation","volume":"40","year":"2008","journal-title":"Transplant Proc"},{"key":"bib22-20231002","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1111\/ajt.14671","article-title":"Causes and timing of end-stage renal disease after living kidney donation","volume":"18","year":"2018","journal-title":"Am J Transplant"},{"key":"bib23-20231002","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/2047-1440-2-2","article-title":"Estimating the long term impact of kidney donation on life expectancy and end stage renal disease","volume":"2","year":"2013","journal-title":"Transplant Res"},{"key":"bib24-20231002","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1681\/ASN.2016101084","article-title":"Quantifying postdonation risk of ESRD in living kidney donors","volume":"28","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"bib25-20231002","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1093\/ndt\/gfw429","article-title":"Long-term risks of kidney living donation: review and position paper by the ERA-EDTA DESCARTES working group","volume":"32","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"bib26-20231002","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1111\/tri.12931","article-title":"What is the significance of end-stage renal disease risk estimation in living kidney donors?","volume":"30","year":"2017","journal-title":"Transpl Int"},{"key":"bib27-20231002","first-page":"2094","article-title":"Kidney-failure risk projection for the living kidney-donor candidate","volume":"374","year":"2016","journal-title":"N Engl J Med"},{"issue":"suppl 1","key":"bib28-20231002","first-page":"S1","article-title":"K\/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification","volume":"39","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"bib29-20231002","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1056\/NEJMoa1000950","article-title":"Racial variation in medical outcomes among living kidney donors","volume":"363","year":"2010","journal-title":"N Engl J Med"},{"key":"bib30-20231002","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1053\/j.ackd.2011.09.005","article-title":"Risks and outcomes of living donation","volume":"19","year":"2012","journal-title":"Adv Chronic Kidney Dis"},{"key":"bib31-20231002","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1126\/science.1193032","article-title":"Association of trypanolytic ApoL1 variants with kidney disease in African Americans","volume":"329","year":"2010","journal-title":"Science"},{"key":"bib32-20231002","first-page":"E2130","article-title":"Evolution of the primate trypanolytic factor APOL1","volume":"111","year":"2014","journal-title":"ProcNatl Acad Sci U S A"},{"key":"bib33-20231002","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1056\/NEJMoa1310345","article-title":"APOL1 risk variants, race, and progression of chronic kidney disease","volume":"369","year":"2013","journal-title":"N Engl J Med"},{"key":"bib34-20231002","first-page":"983","article-title":"APOL1-associated glomerular disease among African-American children: a collaboration of the Chronic Kidney Disease in Children (CKiD) and Nephrotic Syndrome Study Network (NEPTUNE) cohorts","volume":"32","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"bib35-20231002","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1097\/SLA.0000000000002174","article-title":"Apolipoprotein L1 and chronic kidney disease risk in young potential living kidney donors","volume":"267","year":"2018","journal-title":"Ann Surg"},{"key":"bib36-20231002","doi-asserted-by":"crossref","first-page":"2842","DOI":"10.1681\/ASN.2015070763","article-title":"Race, APOL1 risk, and eGFR decline in the general population","volume":"27","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"bib37-20231002","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1681\/ASN.2013010113","article-title":"APOL1 variants associate with increased risk of CKD among African Americans","volume":"24","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"bib38-20231002","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1681\/ASN.2011050519","article-title":"Population-based risk assessment of APOL1 on renal disease","volume":"22","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"bib39-20231002","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1097\/TP.0b013e31822eec39","article-title":"African American living-kidney donors should be screened for APOL1 risk alleles","volume":"92","year":"2011","journal-title":"Transplantation"},{"key":"bib40-20231002","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1681\/ASN.2017060658","article-title":"APOL1 genotype and renal function of black living donors","volume":"29","year":"2018","journal-title":"J Am Soc Nephrol"},{"key":"bib41-20231002","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1053\/j.ajkd.2015.04.046","article-title":"Testing for high-risk APOL1 alleles in potential living kidney donors","volume":"66","year":"2015","journal-title":"Am J Kidney Dis"},{"key":"bib42-20231002","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.semnephrol.2017.07.009","article-title":"Clinical genetic testing for APOL1: Are we there yet?","volume":"37","year":"2017","journal-title":"Semin Nephrol"},{"key":"bib43-20231002","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1111\/ajt.14173","article-title":"Integrating APOL1 gene variants into renal transplantation: considerations arising from the American Society of Transplantation Expert Conference","volume":"17","year":"2017","journal-title":"Am J Transplant"},{"key":"bib44-20231002","first-page":"74","article-title":"Understanding antihypertensive medication use after living kidney donation through linked national registry and pharmacy claims data","volume":"40","year":"2014","journal-title":"Am J Nephrol"},{"key":"bib45-20231002","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/01.TP.0000436731.23554.5e","article-title":"Consistency of racial variation in medical outcomes among publicly and privately insured living kidney donors","volume":"97","year":"2014","journal-title":"Transplantation"},{"key":"bib46-20231002","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1600-6143.2012.04303.x","article-title":"Medical outcomes in African American live kidney donors: a matched cohort study","volume":"13","year":"2013","journal-title":"Am J Transplant"},{"key":"bib47-20231002","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/TP.0b013e31817ba9e3","article-title":"Cardiovascular disease and hypertension risk in living kidney donors: an analysis of health administrative data in Ontario, Canada","volume":"86","year":"2008","journal-title":"Transplantation"},{"key":"bib48-20231002","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1007\/s10157-011-0441-1","article-title":"Kidney function, albuminuria and cardiovascular risk factors in post-operative living kidney donors: a single-center, cross-sectional study","volume":"15","year":"2011","journal-title":"Clin Exp Nephrol"},{"key":"bib49-20231002","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1111\/j.1432-2277.2009.01040.x","article-title":"Twenty four-hour ambulatory blood pressure profiles 12 months post living kidney donation","volume":"23","year":"2010","journal-title":"Transpl Int"},{"key":"bib50-20231002","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1159\/000335070","article-title":"Living donor kidney donation: another form of white coat effect","volume":"35","year":"2012","journal-title":"Am J Nephrol"},{"key":"bib51-20231002","doi-asserted-by":"crossref","first-page":"e13224","DOI":"10.1111\/ctr.13224","article-title":"Ambulatory Blood Pressure Monitoring in living kidney donors: what changes in ten years?","volume":"32","year":"2018","journal-title":"Clin Transplant"},{"key":"bib52-20231002","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ahj.2013.10.024","article-title":"Effect of a reduction in glomerular filtration rate after nephrectomy on arterial stiffness and central hemodynamics: rationale and design of the EARNEST study","volume":"167","year":"2014","journal-title":"Am Heart J"},{"key":"bib53-20231002","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1113\/jphysiol.2014.272328","article-title":"Diabetic kidney disease: from physiology to therapeutics","volume":"592","year":"2014","journal-title":"J Physiol"},{"key":"bib54-20231002","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1046\/j.1523-1755.2003.00712.x","article-title":"Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64)","volume":"63","year":"2003","journal-title":"Kidney Int"},{"key":"bib55-20231002","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.diabet.2014.10.003","article-title":"The impact of hyperfiltration on the diabetic kidney","volume":"41","year":"2015","journal-title":"Diabetes Metab"},{"key":"bib56-20231002","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1681\/ASN.2016060666","article-title":"Glomerular hyperfiltration in diabetes: mechanisms, clinical significance, and treatment","volume":"28","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"bib57-20231002","first-page":"451","article-title":"Increased kidney size, glomerular filtration rate and renal plasma flow in short-term insulin-dependent diabetics","volume":"20","year":"1981","journal-title":"Diabetologia"},{"key":"bib58-20231002","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1056\/NEJM199611283352203","article-title":"Development and progression of renal disease in Pima Indians with non-insulin-dependent diabetes mellitus. Diabetic Renal Disease Study Group","volume":"335","year":"1996","journal-title":"N Engl J Med"},{"key":"bib59-20231002","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1681\/ASN.2016020154","article-title":"The substantial loss of nephrons in healthy human kidneys with aging","volume":"28","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"bib60-20231002","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/ki.2010.128","article-title":"Effects of aging on glomerular function and number in living kidney donors","volume":"78","year":"2010","journal-title":"Kidney Int"},{"key":"bib61-20231002","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.kint.2016.10.014","article-title":"Obesity increases the risk of end-stage renal disease among living kidney donors","volume":"91","year":"2017","journal-title":"Kidney Int"},{"key":"bib62-20231002","doi-asserted-by":"crossref","first-page":"F817","DOI":"10.1152\/ajprenal.2000.278.5.F817","article-title":"Glomerular hemodynamics in severe obesity","volume":"278","year":"2000","journal-title":"Am J Physiol Renal Physiol"},{"key":"bib63-20231002","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1056\/NEJMoa020549","article-title":"Nephron number in patients with primary hypertension","volume":"348","year":"2003","journal-title":"N Engl J Med"},{"key":"bib64-20231002","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1161\/01.CIR.0000158434.69180.2D","article-title":"Low-grade albuminuria and the risks of hypertension and blood pressure progression","volume":"111","year":"2005","journal-title":"Circulation"},{"key":"bib65-20231002","first-page":"451","article-title":"Increased kidney size, glomerular filtration rate and renal plasma flow in short-term insulin-dependent diabetics","volume":"20","year":"1981","journal-title":"Diabetlogia"},{"key":"bib66-20231002","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1093\/ajh\/1.4.335","article-title":"Glomeruli and blood pressure: less of one, more the other?","volume":"1","year":"1988","journal-title":"Am J Hypertens"},{"key":"bib67-20231002","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1056\/NEJMp020168","article-title":"Is microanatomy destiny?","volume":"348","year":"2003","journal-title":"N Engl J Med"},{"key":"bib68-20231002","doi-asserted-by":"crossref","first-page":"S91","DOI":"10.1097\/00004872-199212007-00010","article-title":"Glomerular hypertension: cause and consequence of renal injury","volume":"10","year":"1992","journal-title":"J Hypertens"},{"key":"bib69-20231002","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1053\/j.ajkd.2007.09.013","article-title":"Effect of intrauterine growth restriction on kidney function at young adult age: the Nord Tr\u00f8ndelag Health (HUNT 2) Study","volume":"51","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"bib70-20231002","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1007\/s00467-004-1800-x","article-title":"Comparative renal histomorphometry: a case study of oligonephropathy of prematurity","volume":"20","year":"2005","journal-title":"Pediatr Nephrol"},{"key":"bib71-20231002","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1007\/s00467-003-1186-1","article-title":"Long-term follow-up of extremely low birth weight infants with neonatal renal failure","volume":"18","year":"2003","journal-title":"Pediatr Nephrol"},{"key":"bib72-20231002","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.semnephrol.2009.03.019","article-title":"Nephron mass and cardiovascular and renal disease risks","volume":"29","year":"2009","journal-title":"Semin Nephrol"},{"key":"bib73-20231002","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1038\/ncpneph0344","article-title":"Mechanisms of disease: in utero programming in the pathogenesis of hypertension","volume":"2","year":"2006","journal-title":"Nat Clin Pract Nephrol"},{"key":"bib74-20231002","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1681\/ASN.2004060474","article-title":"Microalbuminuria in adults after prenatal exposure to the Dutch famine","volume":"16","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"bib75-20231002","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1046\/j.1523-1755.1999.00633.x","article-title":"A new dimension to the Barker hypothesis: low birthweight and susceptibility to renal disease","volume":"56","year":"1999","journal-title":"Kidney Int"},{"key":"bib76-20231002","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/0140-6736(93)91224-A","article-title":"Fetal nutrition and cardiovascular disease in adult life","volume":"341","year":"1993","journal-title":"Lancet"},{"key":"bib77-20231002","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/BF00399954","article-title":"Fetal growth and impaired glucose tolerance in men and women","volume":"36","year":"1993","journal-title":"Diabetologia"},{"key":"bib78-20231002","first-page":"1","article-title":"OPTN\/SRTR 2013 Annual Data Report: kidney","volume":"15","year":"2015","journal-title":"Am J Transplant"},{"key":"bib79-20231002","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1056\/NEJMra011295","article-title":"Strategies to improve long-term outcomes after renal transplantation","volume":"346","year":"2002","journal-title":"N Engl J Med"},{"key":"bib80-20231002","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1111\/j.1600-6143.2010.03283.x","article-title":"Long-term renal allograft survival in the United States: a critical reappraisal","volume":"11","year":"2011","journal-title":"Am J Transplant"},{"key":"bib81-20231002","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1111\/j.1600-6143.2012.04033.x","article-title":"The APOL1 genotype of African American kidney transplant recipients does not impact 5-year allograft survival","volume":"12","year":"2012","journal-title":"Am J Transplant"},{"key":"bib82-20231002","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1111\/j.1600-6143.2011.03513.x","article-title":"The APOL1 Gene and allograft survival after kidney transplantation","volume":"11","year":"2011","journal-title":"Am J Transplant"},{"key":"bib83-20231002","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1097\/TP.0000000000000969","article-title":"APOL1 genotype and kidney transplantation outcomes from deceased African American donors","volume":"100","year":"2016","journal-title":"Transplantation"},{"key":"bib84-20231002","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1111\/ajt.13223","article-title":"Apolipoprotein L1 gene variants in deceased organ donors are associated with renal allograft failure","volume":"15","year":"2015","journal-title":"Am J Transplant"},{"key":"bib85-20231002","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1681\/ASN.2014030278","article-title":"A potential role for mechanical forces in the detachment of podocytes and the progression of CKD","volume":"26","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"bib86-20231002","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.kint.2017.02.032","article-title":"Potential relevance of shear stress for slit diaphragm and podocyte function","volume":"91","year":"2017","journal-title":"Kidney Int"},{"key":"bib87-20231002","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.semnephrol.2012.06.004","article-title":"The challenge and response of podocytes to glomerular hypertension","volume":"32","year":"2012","journal-title":"Semin Nephrol"},{"key":"bib88-20231002","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.prostaglandins.2017.01.003","article-title":"Hyperfiltration-associated biomechanical forces in glomerular injury and response: potential role for eicosanoids","volume":"132","year":"2017","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"bib89-20231002","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1093\/ndt\/gfw430","article-title":"Role of biomechanical forces in hyperfiltration-mediated glomerular injury in congenital anomalies of the kidney and urinary tract","volume":"32","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"bib90-20231002","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1007\/s00424-017-2025-8","article-title":"Stressed podocytes-mechanical forces, sensors, signaling and response","volume":"469","year":"2017","journal-title":"Pflugers Arch"},{"key":"bib91-20231002","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1159\/000368493","article-title":"Rheological influence upon the glomerular podocyte and resultant mechanotransduction","volume":"40","year":"2015","journal-title":"Kidney Blood Press Res"},{"key":"bib92-20231002","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1681\/ASN.V123413","article-title":"Podocytes respond to mechanical stress in vitro","volume":"12","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"bib93-20231002","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1159\/000164052","article-title":"Biological alterations of rat podocytes cultured under basolateral hydrostatic pressure","volume":"64","year":"1996","journal-title":"Pathobiology"},{"key":"bib94-20231002","doi-asserted-by":"crossref","first-page":"C276","DOI":"10.1152\/ajpcell.00095.2013","article-title":"Opposing effects of podocin on the gating of podocyte TRPC6 channels evoked by membrane stretch or diacylglycerol","volume":"305","year":"2013","journal-title":"Am J Physiol Cell Physiol"},{"key":"bib95-20231002","first-page":"320","article-title":"A new method for application of force to cells via ferric oxide beads","volume":"435","year":"1998","journal-title":"Pflugers Arch"},{"key":"bib96-20231002","doi-asserted-by":"crossref","first-page":"F1323","DOI":"10.1152\/ajprenal.00335.2014","article-title":"Cyclooxygenase-2, prostaglandin E2, and prostanoid receptor EP2 in fluid flow shear stress-mediated injury in the solitary kidney","volume":"307","year":"2014","journal-title":"Am J Physiol Renal Physiol"},{"key":"bib97-20231002","doi-asserted-by":"crossref","first-page":"F856","DOI":"10.1152\/ajprenal.00196.2005","article-title":"Podocytes are sensitive to fluid shear stress in vitro","volume":"291","year":"2006","journal-title":"Am J Physiol Renal Physiol"},{"key":"bib98-20231002","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s12079-010-0088-9","article-title":"Prostaglandin E(2) is crucial in the response of podocytes to fluid flow shear stress","volume":"4","year":"2010","journal-title":"J Cell Commun Signal"},{"key":"bib99-20231002","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.yexcr.2012.03.011","article-title":"Shear stress induces cell apoptosis via a c-Src-phospholipase D-mTOR signaling pathway in cultured podocytes","volume":"318","year":"2012","journal-title":"Exp Cell Res"},{"key":"bib100-20231002","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.prostaglandins.2012.11.001","article-title":"Fluid flow shear stress upregulates prostanoid receptor EP2 but not EP4 in murine podocytes","volume":"104-105","year":"2013","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"bib101-20231002","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1093\/ndt\/gft387","article-title":"Fluid flow shear stress over podocytes is increased in the solitary kidney","volume":"29","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"bib102-20231002","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1523-1755.2004.00362.x","article-title":"Activation of a local tissue angiotensin system in podocytes by mechanical strain","volume":"65","year":"2004","journal-title":"Kidney Int"},{"key":"bib103-20231002","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1177\/0300060516663094","article-title":"Pentoxifylline plus ACEIs\/ARBs for proteinuria and kidney function in chronic kidney disease: a meta-analysis","volume":"45","year":"2017","journal-title":"J Int Med Res"},{"key":"bib104-20231002","article-title":"Protection against death and renal failure by renin-angiotensin system blockers in patients with diabetes and kidney disease","volume":"17","year":"2016","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"bib105-20231002","doi-asserted-by":"crossref","first-page":"849","DOI":"10.3109\/0886022X.2016.1165065","article-title":"Effect of calcium channels blockers and inhibitors of the renin-angiotensin system on renal outcomes and mortality in patients suffering from chronic kidney disease: systematic review and meta-analysis","volume":"38","year":"2016","journal-title":"Ren Fail"},{"key":"bib106-20231002","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1002\/pds.3941","article-title":"The effect of angiotensin-converting enzyme inhibitor\/angiotensin receptor blocker use on mortality in patients with chronic kidney disease: a meta-analysis of observational studies","volume":"25","year":"2016","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"4 Pt 2","key":"bib107-20231002","first-page":"380S","article-title":"Therapeutic benefit of converting-enzyme inhibition in progressive renal disease","volume":"1","year":"1988","journal-title":"Am J Hypertens"},{"key":"bib108-20231002","first-page":"S242","article-title":"Antihypertensive therapy must control glomerular hypertension to limit glomerular injury","volume":"4","year":"1986","journal-title":"J Hypertens Suppl"},{"key":"bib109-20231002","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1172\/JCI112528","article-title":"Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat","volume":"77","year":"1986","journal-title":"J Clin Invest"},{"key":"bib110-20231002","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1172\/JCI112013","article-title":"Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass","volume":"76","year":"1985","journal-title":"J Clin Invest"},{"key":"bib111-20231002","doi-asserted-by":"crossref","first-page":"F693","DOI":"10.1152\/ajprenal.00331.2003","article-title":"p38 MAP kinase mediates mechanically induced COX-2 and PG EP4 receptor expression in podocytes: implications for the actin cytoskeleton","volume":"286","year":"2004","journal-title":"Am J Physiol Renal Physiol"},{"key":"bib112-20231002","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/j.cellsig.2010.03.014","article-title":"Mechanical stretch and prostaglandin E2 modulate critical signaling pathways in mouse podocytes","volume":"22","year":"2010","journal-title":"Cell Signal"},{"key":"bib113-20231002","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1016\/S0140-6736(14)62459-4","article-title":"Comparative efficacy and safety of blood pressure-lowering agents in adults with diabetes and kidney disease: a network meta-analysis","volume":"385","year":"2015","journal-title":"Lancet"},{"key":"bib114-20231002","doi-asserted-by":"crossref","first-page":"548","DOI":"10.3109\/0886022X.2015.1012995","article-title":"Meta-analysis: the efficacy and safety of combined treatment with ARB and ACEI on diabetic nephropathy","volume":"37","year":"2015","journal-title":"Ren Fail"},{"key":"bib115-20231002","doi-asserted-by":"crossref","first-page":"e1001971","DOI":"10.1371\/journal.pmed.1001971","article-title":"Cardiovascular and renal outcomes of renin-angiotensin system blockade in adult patients with diabetes mellitus: a systematic review with network meta-analyses","volume":"13","year":"2016","journal-title":"PLoS Med"},{"key":"bib116-20231002","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0140-6736(98)10363-X","article-title":"Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria","volume":"354","year":"1999","journal-title":"Lancet"},{"key":"bib117-20231002","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1053\/j.ajkd.2006.04.077","article-title":"Combination therapy with an angiotensin receptor blocker and an ACE inhibitor in proteinuric renal disease: a systematic review of the efficacy and safety data","volume":"48","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"bib118-20231002","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1093\/ajh\/hps038","article-title":"Efficacy and safety of combined vs. single renin-angiotensin-aldosterone system blockade in chronic kidney disease: a meta-analysis","volume":"26","year":"2013","journal-title":"Am J Hypertens"},{"key":"bib119-20231002","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1159\/000350142","article-title":"To treat or not to treat? Cost-effectiveness of ace inhibitors in non-diabetic advanced renal disease\u2014a Dutch perspective","volume":"37","year":"2013","journal-title":"Kidney Blood Press Res"},{"key":"bib120-20231002","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1177\/106002809002400511","article-title":"Angiotensin-converting enzyme inhibitors and renal function","volume":"24","year":"1990","journal-title":"DICP"},{"key":"bib121-20231002","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1056\/NEJM198302173080706","article-title":"Captopril-induced functional renal insufficiency in patients with bilateral renal-artery stenoses or renal-artery stenosis in a solitary kidney","volume":"308","year":"1983","journal-title":"N Engl Med"},{"key":"bib122-20231002","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1111\/j.1600-6143.2007.01928.x","article-title":"Renin angiotensin system blockade in kidney transplantation: a systematic review of the evidence","volume":"7","year":"2007","journal-title":"Am J Transplant"},{"key":"bib123-20231002","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S2213-8587(15)00368-X","article-title":"Ramipril versus placebo in kidney transplant patients with proteinuria: a multicentre, double-blind, randomised controlled trial","volume":"4","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"bib124-20231002","first-page":"S94","article-title":"Renal transplantation in the modern immunosuppressive era in Spain: four-year results from a multicenter database focus on post-transplant cardiovascular disease","volume":"111","year":"2008","journal-title":"Kidney Int Suppl"},{"key":"bib125-20231002","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1053\/j.jrn.2010.03.008","article-title":"One-year serum albumin is an independent predictor of outcomes in kidney transplant recipients","volume":"20","year":"2010","journal-title":"J Ren Nutr"},{"key":"bib126-20231002","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1681\/ASN.2006050543","article-title":"No improvement of patient or graft survival in transplant recipients treated with angiotensin-converting enzyme inhibitors or angiotensin II type 1 receptor blockers: a collaborative transplant study report","volume":"17","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"bib127-20231002","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1097\/TP.0000000000001140","article-title":"Angiotensin-converting enzyme inhibitors-beneficial effects seen in many patient groups may not extend to kidney transplant recipients","volume":"100","year":"2016","journal-title":"Transplantation"},{"key":"bib128-20231002","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1681\/ASN.2005090955","article-title":"Angiotensin-converting enzyme inhibitor or angiotensin II type 1 receptor antagonist therapy is associated with prolonged patient and graft survival after renal transplantation","volume":"17","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"bib129-20231002","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1093\/ndt\/gfr276","article-title":"Renin-angiotensin system blockade and kidney transplantation: a longitudinal cohort study","volume":"27","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"bib130-20231002","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1053\/j.ackd.2015.01.002","article-title":"Hypertension, living kidney donors, and transplantation: where are we today?","volume":"22","year":"2015","journal-title":"Adv Chronic Kidney Dis"},{"key":"bib131-20231002","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1053\/j.ajkd.2016.08.018","article-title":"Renin-angiotensin system blockade and long-term clinical outcomes in kidney transplant recipients: a meta-analysis of randomized controlled trials","volume":"69","year":"2017","journal-title":"Am J Kidney Dis"},{"key":"bib132-20231002","first-page":"CD009191","article-title":"Angiotensin-converting enzyme (ACE) inhibitors for proteinuria and microalbuminuria in people with sickle cell disease","volume":"6","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"bib133-20231002","first-page":"CD012380","article-title":"Interventions for chronic kidney disease in people with sickle cell disease","volume":"7","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"bib134-20231002","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMoa1402685","article-title":"Blood pressure in early autosomal dominant polycystic kidney disease","volume":"371","year":"2014","journal-title":"N Engl J Med"},{"key":"bib135-20231002","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1056\/NEJMoa1402686","article-title":"Angiotensin blockade in late autosomal dominant polycystic kidney disease","volume":"371","year":"2014","journal-title":"N Engl J Med"},{"key":"bib136-20231002","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1093\/ndt\/gfm237","article-title":"No clear evidence of ACEi efficacy on the progression of chronic kidney disease in children with hypodysplastic nephropathy\u2014report from the ItalKid Project database","volume":"22","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"bib137-20231002","doi-asserted-by":"crossref","first-page":"F22","DOI":"10.1152\/ajprenal.00325.2017","article-title":"Mechanotransduction signaling in podocytes from fluid flow shear stress","volume":"314","year":"2018","journal-title":"Am J Physiol Renal Physiol"},{"issue":"4 Pt 2","key":"bib138-20231002","first-page":"F613","article-title":"Selective increase of cyclooxygenase-2 expression in a model of renal ablation","volume":"275","year":"1998","journal-title":"Am J Physiol"},{"issue":"5 Pt 2","key":"bib139-20231002","first-page":"F829","article-title":"Regulatory role of prostanoids in glomerular microcirculation of remnant nephrons","volume":"252","year":"1987","journal-title":"Am J Physiol"},{"key":"bib140-20231002","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1159\/000183676","article-title":"Prostaglandin and thromboxane formation in glomeruli from rats with reduced renal mass","volume":"42","year":"1986","journal-title":"Nephron"},{"key":"bib141-20231002","first-page":"F1057","article-title":"Prostaglandins do not mediate impaired autoregulation or increased renin secretion in remnant rat kidneys","volume":"263","year":"1992","journal-title":"Am J Physiol"},{"key":"bib142-20231002","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1440-1681.2007.04534.x","article-title":"Cyclo-oxygenase-2 inhibition attenuates the progression of nephropathy in uninephrectomized diabetic rats","volume":"34","year":"2007","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"4 Pt 2","key":"bib143-20231002","first-page":"848","article-title":"Effect of cyclooxygenase-2 inhibition on renal function after renal ablation","volume":"34","year":"1999","journal-title":"Hypertension"},{"key":"bib144-20231002","doi-asserted-by":"crossref","first-page":"F368","DOI":"10.1152\/ajprenal.00500.2005","article-title":"Role of renal cortical cyclooxygenase-2 expression in hyperfiltration in rats with high-protein intake","volume":"291","year":"2006","journal-title":"Am J Physiol Renal Physiol"},{"key":"bib145-20231002","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1159\/000057615","article-title":"Subtotal nephrectomy stimulates cyclooxygenase 2 expression and prostacyclin synthesis in the rat remnant kidney","volume":"91","year":"2002","journal-title":"Nephron"},{"key":"bib146-20231002","doi-asserted-by":"crossref","first-page":"2822","DOI":"10.1158\/0008-5472.CAN-15-0125","article-title":"Definition of Prostaglandin E2-EP2 signals in the colon tumor microenvironment that amplify inflammation and tumor growth","volume":"75","year":"2015","journal-title":"Cancer Res"},{"key":"bib147-20231002","doi-asserted-by":"crossref","first-page":"4454","DOI":"10.1021\/jm401431x","article-title":"Prostanoid receptor EP2 as a therapeutic target","volume":"57","year":"2014","journal-title":"J Med Chem"},{"key":"bib148-20231002","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/ki.2015.316","article-title":"Phenotyping by magnetic resonance imaging nondestructively measures glomerular number and volume distribution in mice with and without nephron reduction","volume":"89","year":"2016","journal-title":"Kidney Int"},{"key":"bib149-20231002","first-page":"316ra193","article-title":"Tissue transcriptome-driven identification of epidermal growth factor as a chronic kidney disease biomarker","volume":"7","year":"2015","journal-title":"Sci Transl Med"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00007890-201810000-00016","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T05:36:15Z","timestamp":1696224975000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007890-201810000-00016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":149,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000002304","relation":{},"ISSN":["1534-6080","0041-1337"],"issn-type":[{"value":"1534-6080","type":"electronic"},{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]}}}